These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31245982)

  • 1. Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report.
    Ekinci C; Kayıran A; Özdemir H
    Turk J Ophthalmol; 2019 Jun; 49(3):175-177. PubMed ID: 31245982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
    Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracrystalline Ozurdex
    Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
    Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
    Gu X; Yu X; Song S; Dai H
    Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.
    Simsek M; Citirik M; Ozates S; Ozkoyuncu D
    Indian J Ophthalmol; 2018 Jun; 66(6):831-836. PubMed ID: 29785994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone Intravitreal Implant Therapy for Retinal Vein Occlusion Macular Oedema and Conversion to Ranibizumab in Clinical Practice.
    Balal S; Than J; Tekriwal S; Lobo A
    Ophthalmologica; 2018; 239(1):36-44. PubMed ID: 28950262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
    Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
    Bakri SJ; Omar AF
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of vitreomacular adhesion in eyes with macular oedema secondary to retinal vein occlusion selected for intravitreal injections.
    Maggio E; Maraone G; Mete M; Vingolo EM; Grenga PL; Guerriero M; Pertile G
    Acta Ophthalmol; 2021 Nov; 99(7):e1154-e1161. PubMed ID: 33421346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surprises during intravitreal drug delivery-a report of three cases.
    Venkatesh P; Chawla R; Shah B; Garg SP
    Digit J Ophthalmol; 2017; 23(1):33-35. PubMed ID: 28924419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular pseudohole development after sustained-release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusion.
    Di Antonio L; Toto L; Carpineto P; Mastropasqua A; De Nicola C; Mastropasqua L
    Eur J Ophthalmol; 2014; 24(1):134-7. PubMed ID: 23709332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment.
    Altunel O; Duru N; Goktas A; Ozkose A; Goktas E; Atas M
    Int Ophthalmol; 2017 Apr; 37(2):333-339. PubMed ID: 27221365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OUTER RETINAL LAYER CHANGES AFTER DEXAMETHASONE IMPLANT FOR CENTRAL RETINAL VEIN OCCLUSION.
    Battaglia Parodi M; Iacono P; Scaramuzzi M; Bandello F
    Retina; 2017 Oct; 37(10):1888-1895. PubMed ID: 28030428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic roof collapse after intravitreal injection of dexamethasone implant, a case report.
    Romano F; Albertini GC; Arrigo A; Battaglia Parodi M; Bandello F
    Eur J Ophthalmol; 2019 Jul; 29(4):NP16-NP18. PubMed ID: 30353744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema.
    Choi EY; Kang HG; Lee SC; Kim M
    BMC Ophthalmol; 2019 Apr; 19(1):92. PubMed ID: 30999889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAFETY AND FEASIBILITY OF A NOVEL 25-GAUGE BIODEGRADABLE IMPLANT OF DEXAMETHASONE FOR TREATMENT OF MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION: A PHASE I CLINICAL TRIAL.
    Cunha RB; Siqueira RC; Messias A; Scott IU; Fialho SL; Cunha-Junior ADS; Jorge R
    Retin Cases Brief Rep; 2018 Winter; 12(1):50-58. PubMed ID: 27632583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.